Stifel Financial’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $134K | Sell |
196,556
-7,022
| -3% | -$4.79K | ﹤0.01% | 3328 |
|
|
2025
Q1 | $185K | Sell |
203,578
-7,783
| -4% | -$7.09K | ﹤0.01% | 3205 |
|
|
2024
Q4 | $230K | Buy |
211,361
+17,139
| +9% | +$18.7K | ﹤0.01% | 3101 |
|
|
2024
Q3 | $147K | Buy |
194,222
+232
| +0.1% | +$176 | ﹤0.01% | 3190 |
|
|
2024
Q2 | $241K | Buy |
193,990
+1,398
| +0.7% | +$1.73K | ﹤0.01% | 3022 |
|
|
2024
Q1 | $364K | Sell |
192,592
-1,383
| -0.7% | -$2.61K | ﹤0.01% | 2794 |
|
|
2023
Q4 | $512K | Buy |
193,975
+46,763
| +32% | +$123K | ﹤0.01% | 2544 |
|
|
2023
Q3 | $339K | Sell |
147,212
-109
| -0.1% | -$251 | ﹤0.01% | 2721 |
|
|
2023
Q2 | $538K | Buy |
147,321
+857
| +0.6% | +$3.13K | ﹤0.01% | 2476 |
|
|
2023
Q1 | $523K | Buy |
146,464
+16,101
| +12% | +$57.5K | ﹤0.01% | 2488 |
|
|
2022
Q4 | $372K | Buy |
130,363
+63,707
| +96% | +$182K | ﹤0.01% | 2638 |
|
|
2022
Q3 | $148K | Hold |
66,656
| – | – | ﹤0.01% | 3029 |
|
|
2022
Q2 | $165K | Hold |
66,656
| – | – | ﹤0.01% | 3059 |
|
|
2022
Q1 | $325K | Hold |
66,656
| – | – | ﹤0.01% | 2834 |
|
|
2021
Q4 | $754K | Buy |
66,656
+770
| +1% | +$8.71K | ﹤0.01% | 2324 |
|
|
2021
Q3 | $960K | Hold |
65,886
| – | – | ﹤0.01% | 2130 |
|
|
2021
Q2 | $768K | Hold |
65,886
| – | – | ﹤0.01% | 2293 |
|
|
2021
Q1 | $804K | Hold |
65,886
| – | – | ﹤0.01% | 2140 |
|
|
2020
Q4 | $824K | Hold |
65,886
| – | – | ﹤0.01% | 1986 |
|
|
2020
Q3 | $991K | Hold |
65,886
| – | – | ﹤0.01% | 1636 |
|
|
2020
Q2 | $1.62M | Buy |
65,886
+10,031
| +18% | +$246K | ﹤0.01% | 1270 |
|
|
2020
Q1 | $792K | Hold |
55,855
| – | – | ﹤0.01% | 1573 |
|
|
2019
Q4 | $887K | Hold |
55,855
| – | – | ﹤0.01% | 1913 |
|
|
2019
Q3 | $471K | Hold |
55,855
| – | – | ﹤0.01% | 2202 |
|
|
2019
Q2 | $502K | Buy |
+55,855
| New | +$502K | ﹤0.01% | 2204 |
|